{"id":400605842,"name":"W STRATEGIES, LLC","slug":"w-strategies-llc","totalIncome":26760000,"filings":595,"yearlyIncome":[{"year":2018,"income":3160000},{"year":2019,"income":3100000},{"year":2020,"income":3270000},{"year":2021,"income":3750000},{"year":2022,"income":4180000},{"year":2023,"income":3740000},{"year":2024,"income":3000000},{"year":2025,"income":2560000}],"clients":["MERCK & CO., INC.","SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS","23ANDME, INC.","ABBOTT LABORATORIES","ABBVIE INC.","ACTELION PHARMACEUTICALS US, INC","ALEXION PHARMACEUTICALS","ASTRAZENECA PHARMACEUTICALS LP","BIOGEN","CALIFORNIA LIFE SCIENCES","CONSUMER HEALTHCARE PRODUCTS ASSOCIATION","ENOVIS","GLAXOSMITHKLINE","IPSEN BIOPHARMACEUTICALS, INC.","JUUL LABS INC","MEDTRONIC, INC.","MCKESSON CORPORATION","PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","SANOFI U.S. SERVICES, INC.","UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA)","GLOBAL BLOOD THERAPEUTICS","TESARO, INC.","GILEAD SCIENCES, INC.","MODERNA, INC.","INCYTE CORPORATION","SECURE IDENTITY, LLC","IOVANCE BIOTHERAPEUTICS, INC.","VIR BIOTECHNOLOGY, INC.","THERMO FISHER SCIENTIFIC INC","KARUNA THERAPEUTICS","STOKE THERAPEUTICS","DELFI DIAGNOSTICS","OTSUKA AMERICA PHARMACEUTICAL, INC.","PHLOW CORP.","ALVEO TECHNOLOGIES","ELEVATEBIO","PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL"],"lobbyists":["DARREN WILLCOX"],"issues":["HCR","MMM","MED","TAX","BUD","VET","TRD","DEF","TOB","CSP","PHA","IMM","HOM","SCI","CPT",null],"clientCount":37,"years":[2018,2019,2020,2021,2022,2023,2024,2025]}